Tampaki, M.; Ionas, E.; Hadziyannis, E.; Deutsch, M.; Malagari, K.; Koskinas, J.
Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Cancers 2020, 12, 212.
https://doi.org/10.3390/cancers12010212
AMA Style
Tampaki M, Ionas E, Hadziyannis E, Deutsch M, Malagari K, Koskinas J.
Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Cancers. 2020; 12(1):212.
https://doi.org/10.3390/cancers12010212
Chicago/Turabian Style
Tampaki, Maria, Evangelos Ionas, Emilia Hadziyannis, Melanie Deutsch, Katerina Malagari, and John Koskinas.
2020. "Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma" Cancers 12, no. 1: 212.
https://doi.org/10.3390/cancers12010212
APA Style
Tampaki, M., Ionas, E., Hadziyannis, E., Deutsch, M., Malagari, K., & Koskinas, J.
(2020). Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Cancers, 12(1), 212.
https://doi.org/10.3390/cancers12010212